Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer

Despite improvements in prevention and management of colorectal cancer (CRC), uncontrolled tumor growth with metastatic spread to distant organs remains an important clinical concern. Genetic deletion of CD39, the dominant vascular and immune cell ectonucleotidase, has been shown to delay tumor grow...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Künzli, Beat M., Bernlochner, Maria-Isabell, Rath, Stephan, Käser, Samuel, Csizmadia, Eva, Enjyoji, Keiichi, Cowan, Peter, d’Apice, Anthony, Dwyer, Karen, Rosenberg, Robert, Perren, Aurel, Friess, Helmut, Maurer, Christoph A., Robson, Simon C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Netherlands 2011
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3146639/
https://ncbi.nlm.nih.gov/pubmed/21484085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11302-011-9228-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak